Objectives: To investigate the prevalence of metallo-b-lactamases (MBLs) and Tn6001 in carbapenem-non-susceptible Pseudomonas aeruginosa (CNSPA). The CNSPA included extensively drug-resistant P. aeruginosa (XDRPA) and non-XDRPA isolates in Taiwan. Methods: A total of 308 CNSPA isolates collected at a medical centre from 2000 to 2005 and 26 XDRPA collected from six medical centres in different regions of Taiwan in 2003 were included. MBL genes and Tn6001 were detected by PCR. Clonal relatedness was determined by PFGE. Results: Of the 308 CNSPA isolates, 30 (10%) were XDRPA, including 27 (9%) colistin-only-susceptible (COS) and 3 (1%) colistin-only-intermediate (COI) P. aeruginosa. blaVIM-3 was found in 16 (53%) isolates of the XDRPA (n530), ...
Introduction: Researching carbapenem-resistant isolates enables the identification of carbapenemase-...
[[abstract]]Between 2003 and 2009, the prevalence of extensively drug-resistant Pseudomonas aerugino...
[[abstract]]Between 2003 and 2009, the prevalence of extensively drug-resistant Pseudomonas aerugino...
Objectives: The present study was conducted to investigate acquired beta- lactamases and their genet...
Objectives: To investigate the epidemiological traits of metallo-beta-lactamase (MBL)-producing Pseu...
OBJECTIVES: To investigate the epidemiological traits of metallo-β-lactamase (MBL)-producing Pseudo...
[[abstract]]Seventy-two isolates of carbapenem-resistant Pseudomonas aeruginosa (CRPA) collected thr...
[[abstract]]Seventy-two isolates of carbapenem-resistant Pseudomonas aeruginosa (CRPA) collected thr...
Seventy-two isolates of carbapenem-resistant Pseudomonas aeruginosa (CRPA ) collected through the Ta...
ABSTRACT: Objectives: To determine the in vitro activities of ceftolozane/tazobactam (C/T) and comp...
Introduction: Carbapenems are the primary choice of treatment for nosocomial Pseudomonas aeruginosa ...
Objectives: To investigate the epidemiological traits of metallo-b-lactamase (MBL)-producing Pseudom...
Introduction: Carbapenems are the primary choice of treatment for nosocomial Pseudomonas aeruginosa ...
Objectives: Recently, resistance to extended-spectrum cephalosporins due to acquired b-lactamases ha...
Objectives: Recently, resistance to extended-spectrum cephalosporins due to acquired b-lactamases ha...
Introduction: Researching carbapenem-resistant isolates enables the identification of carbapenemase-...
[[abstract]]Between 2003 and 2009, the prevalence of extensively drug-resistant Pseudomonas aerugino...
[[abstract]]Between 2003 and 2009, the prevalence of extensively drug-resistant Pseudomonas aerugino...
Objectives: The present study was conducted to investigate acquired beta- lactamases and their genet...
Objectives: To investigate the epidemiological traits of metallo-beta-lactamase (MBL)-producing Pseu...
OBJECTIVES: To investigate the epidemiological traits of metallo-β-lactamase (MBL)-producing Pseudo...
[[abstract]]Seventy-two isolates of carbapenem-resistant Pseudomonas aeruginosa (CRPA) collected thr...
[[abstract]]Seventy-two isolates of carbapenem-resistant Pseudomonas aeruginosa (CRPA) collected thr...
Seventy-two isolates of carbapenem-resistant Pseudomonas aeruginosa (CRPA ) collected through the Ta...
ABSTRACT: Objectives: To determine the in vitro activities of ceftolozane/tazobactam (C/T) and comp...
Introduction: Carbapenems are the primary choice of treatment for nosocomial Pseudomonas aeruginosa ...
Objectives: To investigate the epidemiological traits of metallo-b-lactamase (MBL)-producing Pseudom...
Introduction: Carbapenems are the primary choice of treatment for nosocomial Pseudomonas aeruginosa ...
Objectives: Recently, resistance to extended-spectrum cephalosporins due to acquired b-lactamases ha...
Objectives: Recently, resistance to extended-spectrum cephalosporins due to acquired b-lactamases ha...
Introduction: Researching carbapenem-resistant isolates enables the identification of carbapenemase-...
[[abstract]]Between 2003 and 2009, the prevalence of extensively drug-resistant Pseudomonas aerugino...
[[abstract]]Between 2003 and 2009, the prevalence of extensively drug-resistant Pseudomonas aerugino...